Stock Report

All about this stock under one free report Last Updated: 04-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Indo Us Bio-Tech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: INDOUS | BSE: 541304

₹66.31

up-down-arrow ₹-1.64 (-2.41%)

As on 03-Nov-2026IST

Market cap

info icon

₹133 Cr

Revenue (TTM)

info icon

₹97 Cr

P/E Ratio

info icon

30.7

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -54.39 -51.22 -18.31 12.20 22.47
EBIT -178.06 -172.85 -58.70 -7.81 25.08
Net Profit -220.91 -206.37 -74.36 -19.11 20.82
EPS -220.90 -206.37 -74.36 -19.11 13.33
Book Value -- -- 17.85 19.30 25.57
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 15.1714.487.9414.5917.18
Net Margin info 12.9312.194.4611.8815.64
Return on equity info 17.4817.064.7015.3423.03
Return on Capital info 16.6916.11--14.5121.15
Return on Assets info 13.4012.503.3611.4217.98
Debt to Equity (x) info ----0.090.400.19

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
14.51
21.15
14.42
14.62
Peer Median
--
13.95
16.69
14.62
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

4.70

Lower than Peers by 9.91

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
4.70
15.34
23.03
14.08
15.51
Peer Median
14.61
15.61
20.05
11.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

3.36

Lower than Peers by 3.61

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
3.36
11.42
17.98
10.81
11.67
Peer Median
6.97
6.49
11.42
4.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

7.94

Higher than Peers by 1.36

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
7.94
14.59
17.18
13.74
13.88
Peer Median
6.59
6.60
9.04
8.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

4.46

Lower than Peers by 1.04

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
4.46
11.88
15.64
11.28
11.72
Peer Median
5.50
5.97
11.50
4.52
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
12.70
16.72
12.43
13.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-18.31

Lower than Peers by 31.90

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
-18.31
6.36
42.56
17.96
23.36
Peer Median
13.59
10.21
15.57
15.22
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-58.70

Lower than Peers by 60.89

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
-58.70
-9.66
78.31
16.78
31.64
Peer Median
2.19
-14.77
5.87
15.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-74.36

Lower than Peers by 81.05

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
-74.36
-19.33
97.15
13.96
38.25
Peer Median
6.69
-12.43
3.10
13.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-74.36

--

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
-74.36
-19.33
97.15
13.96
26.40
Peer Median
--
-15.18
1.38
5.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
17.85
25.13
15.14
40.17
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.09

Higher than Peers by 0.08

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
0.09
0.40
0.19
0.23
0.21
Peer Median
0.01
0.17
0.24
0.31
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
0.37
0.13
0.17
0.15
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.19

Higher than Peers by 1.22

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
3.19
3.05
5.31
4.19
4.87
Peer Median
1.97
1.99
2.02
1.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.03

No difference

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
1.03
0.52
0.98
1.22
2.68
Peer Median
1.03
0.96
0.95
0.93
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

2.70

Lower than Peers by 2.84

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
2.70
7.19
12.09
6.79
7.15
Peer Median
5.54
6.31
7.46
4.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

37.49

Higher than Peers by 15.72

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
37.49
12.46
14.45
26.15
40.07
Peer Median
21.77
21.96
18.52
21.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.75

Lower than Peers by 0.21

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
0.75
0.96
1.15
0.95
1.00
Peer Median
0.97
1.14
1.34
1.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
47.52
59.84
109.71
133.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
281.98
215.16
197.06
148.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
148.07
592.15
-53.89
302.49
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
181.43
-317.15
360.66
-20.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

30.68

Higher than Peers by 17.26

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
30.68
14.96
18.15
53.94
14.71
Peer Median
13.43
15.16
20.37
21.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.45

Lower than Peers by 0.07

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
1.45
2.12
3.76
7.09
3.91
Peer Median
1.52
1.61
2.46
3.72
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

19.56

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
19.56
13.31
16.21
41.20
23.84
Peer Median
--
10.66
15.92
19.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

133

Lower than Peers by 208

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Indo Us Bio-Tech
133
196
295
445
213
Peer Median
341
317
706
421
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds